TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma ; volume:7 ; number:1 ; day:26 ; month:11 ; year:2019 ; pages:1-9 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (26.11.2019), 1-9, 12.2019
- Creator
-
Reilley, Matthew J.
Morrow, Brittany
Ager, Casey R.
Liu, Arthur
Hong, David S.
Curran, Michael A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0811-x
- URN
-
urn:nbn:de:101:1-2020032122494855549162
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Reilley, Matthew J.
- Morrow, Brittany
- Ager, Casey R.
- Liu, Arthur
- Hong, David S.
- Curran, Michael A.
- SpringerLink (Online service)
Other Objects (12)
Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
Cytomegalovirus containing TRP2 antigen provides protective immunity against the poorly immunogenic B16BL6-D5 melanoma
Regress
Regreß
Regreß
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers
Regress - Arzthaftungsprozesse
Who cooperates on R & D?
Versicherungsfragen, Gerichtsverfahren, Regress
Produktrückruf und Regress
Progress durch Regress
Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling
Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
Cytomegalovirus containing TRP2 antigen provides protective immunity against the poorly immunogenic B16BL6-D5 melanoma
Regress
Regreß
Regreß
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers
Regress - Arzthaftungsprozesse
Who cooperates on R & D?
Versicherungsfragen, Gerichtsverfahren, Regress
Produktrückruf und Regress
Progress durch Regress
Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling
Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
Cytomegalovirus containing TRP2 antigen provides protective immunity against the poorly immunogenic B16BL6-D5 melanoma
Regress
Regreß
Regreß
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers
Regress - Arzthaftungsprozesse
Who cooperates on R & D?
Versicherungsfragen, Gerichtsverfahren, Regress
Produktrückruf und Regress
Progress durch Regress